share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Atkinson Edward Morrow III

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Atkinson Edward Morrow III

福泰制药 | 4:持股变动声明-高管 Atkinson Edward Morrow III
美股sec公告 ·  06/13 16:15
Moomoo AI 已提取核心信息
Edward Morrow III, EVP and Chief Technical Operations Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of 14,112 shares of common stock over two consecutive days. On June 11, 2024, Morrow disposed of 6,824 shares at a price of $481.96 per share, followed by the sale of 7,288 shares on June 12, 2024, at $478.00 per share. The transactions resulted in a total market value of $6,772,559.04. Following these sales, Morrow directly holds 15,972 shares of Vertex Pharmaceuticals.
Edward Morrow III, EVP and Chief Technical Operations Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of 14,112 shares of common stock over two consecutive days. On June 11, 2024, Morrow disposed of 6,824 shares at a price of $481.96 per share, followed by the sale of 7,288 shares on June 12, 2024, at $478.00 per share. The transactions resulted in a total market value of $6,772,559.04. Following these sales, Morrow directly holds 15,972 shares of Vertex Pharmaceuticals.
福泰制药公司执行副总裁兼首席技术运营官Edward Morrow III连续两天共计出售了14,112股普通股。2024年6月11日,Morrow以每股481.96美元的价格剥离了6,824股,紧接着于2024年6月12日以每股478.00美元的价格出售了7,288股,交易结果总市值为6,772,559.04美元。在此次交易后,Morrow直接持有福泰制药15,972股。
福泰制药公司执行副总裁兼首席技术运营官Edward Morrow III连续两天共计出售了14,112股普通股。2024年6月11日,Morrow以每股481.96美元的价格剥离了6,824股,紧接着于2024年6月12日以每股478.00美元的价格出售了7,288股,交易结果总市值为6,772,559.04美元。在此次交易后,Morrow直接持有福泰制药15,972股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息